Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.01
+0.16 (2.74%)
At close: Jun 26, 2026, 4:00 PM EDT
5.96
-0.05 (-0.86%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Vanda Pharmaceuticals stock have an average target of 14.9, with a low estimate of 7.50 and a high estimate of 21. The average target predicts an increase of 147.92% from the current stock price of 6.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $21 | Buy | Reiterates | $21 | +249.42% | Jun 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $18 | Buy | Maintains | $18 | +199.50% | May 7, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +182.86% | Feb 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 | Buy | Maintains | $11 | +83.03% | Feb 23, 2026 |
| Jefferies | Jefferies | Hold Maintains $5 → $7.5 | Hold | Maintains | $5 → $7.5 | +24.79% | Dec 31, 2025 |
Financial Forecast
Revenue This Year
262.00M
from 216.11M
Increased by 21.24%
Revenue Next Year
356.60M
from 262.00M
Increased by 36.10%
EPS This Year
0.96
EPS Next Year
1.04
from 0.96
Increased by 8.33%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 266.8M | 377.4M | |
| Avg | 262.0M | 356.6M | |
| Low | 259.6M | 338.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.5% | 44.0% | |
| Avg | 21.2% | 36.1% | |
| Low | 20.1% | 29.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.96 | 1.04 | |
| Avg | 0.96 | 1.04 | |
| Low | 0.96 | 1.04 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 8.3% | -17.3% |
| Avg | 8.3% | -17.3% |
| Low | 8.3% | -17.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.